Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Human Genetics|April 1, 1993
An interleukin-8 (IL-8) cDNA clone identifies a frequent HindIII polymorphismM F Fey, A ToblerBritish Journal of Haematology|October 1, 1996
Detection of microsatellite markers in leukaemia using DNA from archival bone marrow smearsT Pabst, J Schwaller, A Tobler, et al.Human Genetics|November 1, 1993
A myeloblastin/proteinase-3 cDNA clone identifies a BglII and a PvuII restriction fragment length polymorphismJ Schwaller, T Chen, M F Fey, et al.British Journal of Rheumatology|July 1, 1994
Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patientsM Seitz, P Loetscher, M F Fey, et al.Leukemia Research|July 1, 1995
The induction kinetics of Il-8 messenger RNA in HL60 cells demonstrate the participation of negative-acting gene(s)R W Meier, G Niklaus, M F Fey, et al.Schweizerische Medizinische Wochenschrift|January 11, 1994
[Prognostic value of bone marrow examinations on day 8 and day 17 of the first induction therapy cycle in acute myeloid leukemia]K Zingg, A von Rohr, M F Fey, et al.Pediatric Research|August 29, 2000
Interleukin-8 expression by fetal and neonatal pulmonary cells in hyaline membrane disease and amniotic infectionA Gähler, T Stallmach, J Schwaller, et al.Biochemical and Biophysical Research Communications|April 29, 1994
Myeloblastin/proteinase 3 belongs to the set of negatively regulated primary response genes expressed during in vitro myeloid differentiationT Chen, R Meier, A Ziemiecki, et al.Journal of Cellular Physiology|October 1, 1995
Inhibition of the arachidonic acid pathway prevents induction of IL-8 mRNA by phorbol ester and changes the release of IL-8 from HL 60 cells: differential inhibition of induced expression of IL-8, TNF-alpha, IL-1 alpha, and IL-1 betaR W Meier, G Niklaus, B Dewald, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
The polymerase chain reaction: a new tool for the detection of minimal residual disease in haematological malignanciesM F Fey, A E Kulozik, T E Hansen-Hagge, et al.Pageof 21